Clinical Trial Update: Magnesium Sulphate for Preterm Birth (MASP Study) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating magnesium sulfate for prevention of preterm birth outcomes related to cerebral palsy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Palsy

Drugs mentioned

• Magnesium sulfate (magnesium sulfate)

Snippet

Sponsor: Hvidovre University Hospital | Conditions: Cerebral Palsy | Phase 3 | Status: COMPLETED